首页> 美国卫生研究院文献>ACS Chemical Neuroscience >Lithium Inositol and Mitochondria
【2h】

Lithium Inositol and Mitochondria

机译:锂肌醇和线粒体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Our recent DNA-microarray and proteomics studies searching for pathways affected both by chronic lithium treatment and by knockout of each of two genes (IMPA1 or Slc5a3) encoding for proteins related to inositol metabolism, indicated up-regulation of mitochondria-related genes and autophagy-related proteins in the frontal cortex. Differently from previously reported observations of aberrant mitochondrial function in bipolar patients which leave a causality relationship between mitochondrial dysfunction and bipolar disorder an open question, the behavioral results of our recent report following rotenone treatment tempt us to speculate that mitochondrial dysfunction predisposes manic behavior and that drugs targeted to ameliorate mitochondrial function are potential preventers of bursting manic episodes. However, the promiscuity of the involvement of mitochondrial dysfunction and impaired autophagy in the pathophysiology of psychiatric and neurodegenerative disorders raises questions regarding the credibility and relevance of these findings.
机译:我们最近进行的DNA芯片和蛋白质组学研究寻找受慢性锂治疗和敲除编码与肌醇代谢相关蛋白的两个基因(IMPA1或Slc5a3)中的每一个均受影响的途径,这表明线粒体相关基因和自噬的上调额叶皮质中的相关蛋白。与先前报道的在双相情感障碍患者中线粒体功能异常导致线粒体功能障碍与双相情感障碍之间存在因果关系的观察结果不同,悬而未决的问题是,鱼藤酮治疗后我们最近报告的行为结果诱使我们推测线粒体功能障碍是躁狂行为的先兆,而药物旨在改善线粒体功能的目标是预防躁狂发作的潜在预防剂。但是,精神病和神经退行性疾病的病理生理中线粒体功能障碍和自噬功能受损的混杂性引起了关于这些发现的可信度和相关性的疑问。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号